Blueprint Medicines Corp

BROWN ADVISORY INC BPMC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/13/2025

Shares

458,559

Value ($000)

58,778

Weight

0.1%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/13/2025	58,778	0.1%	458,559	6/30/2025
2025 Q1	4/30/2025	51,501	0.1%	581,864	3/31/2025
2024 Q4	2/14/2025	50,481	0.1%	578,780	12/31/2024
2024 Q3	11/13/2024	54,924	0.1%	593,768	9/30/2024
2024 Q2	8/14/2024	66,607	0.1%	617,992	6/30/2024
2024 Q1	4/24/2024	63,970	0.1%	674,362	3/31/2024
2023 Q4	2/8/2024	62,716	0.1%	679,920	12/31/2023
2023 Q3	10/25/2023	32,193	0.1%	641,039	9/30/2023
2023 Q2	7/31/2023	40,144	0.1%	635,196	6/30/2023
2023 Q1	5/8/2023	28,497	0.0%	633,408	3/31/2023
2022 Q4	2/13/2023	26,342	0.0%	601,282	12/31/2022
2022 Q3	11/14/2022	64,045	0.1%	971,994	9/30/2022
2022 Q2	11/14/2022	50,271	0.1%	995,269	6/30/2022
2022 Q1	11/14/2022	60,447	0.1%	946,255	3/31/2022
2021 Q4	1/27/2022	93,856	0.1%	876,255	12/31/2021
2021 Q3	11/12/2021	87,303	0.1%	849,175	9/30/2021
2021 Q2	7/29/2021	70,004	0.1%	795,858	6/30/2021
2021 Q1	5/14/2021	73,584	0.1%	756,809	3/31/2021
2020 Q4	2/12/2021	82,614	0.1%	736,633	12/31/2020
2020 Q3	11/16/2020	66,954	0.1%	722,259	9/30/2020
2020 Q2	8/14/2020	55,495	0.1%	711,476	6/30/2020
2020 Q1	5/15/2020	25,262	0.1%	431,975	3/31/2020
2019 Q4	2/14/2020	30,231	0.1%	377,373	12/31/2019